We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+21.94%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$34.9B
AUM Growth
+$6.68B
(+24%)
Cap. Flow
+$1.95B
Cap. Flow
% of AUM
5.58%
Top 10 Holdings %
Top 10 Hldgs %
7.42%
Holding
3,971
New
955
Increased
1,167
Reduced
1,145
Closed
694
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$257M |
| 2 |
Boston Scientific
BSX
|
+$228M |
| 3 |
Meta Platforms (Facebook)
META
|
+$225M |
| 4 |
Amazon
AMZN
|
+$220M |
| 5 |
S&P Global
SPGI
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$252M |
| 2 |
PayPal
PYPL
|
+$252M |
| 3 |
Walt Disney
DIS
|
+$217M |
| 4 |
Chevron
CVX
|
+$206M |
| 5 |
Best Buy
BBY
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.11% |
| 2 | Consumer Discretionary | 13.39% |
| 3 | Financials | 9.06% |
| 4 | Healthcare | 8.71% |
| 5 | Consumer Staples | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RYZ
2251
Ryerson Holding Corp
RYZ
$1.46B
| $707K | ﹤0.01% |
+51,860
| New | +$508K |
|
2252
CALL
Trupanion
TRUP
$1.18B
| $706K | ﹤0.01% |
+5,900
| New | +$557K |
|
2253
ADC Therapeutics
ADCT
$144M
| $704K | ﹤0.01% |
+21,997
| New | +$721K |
|
2254
Antero Resources
AR
$10.7B
| $704K | ﹤0.01% |
+129,136
| New | +$530K |
|
2255
Rhythm Pharmaceuticals
RYTM
$7.96B
| $704K | ﹤0.01% |
23,681
+1,939
| +9% | +$49.3K |
|
|
TRVN
2256
DELISTED
Trevena, Inc.
TRVN
| $703K | ﹤0.01% |
+526
| New | +$837K |
|
|
UROV
2257
DELISTED
Urovant Sciences Ltd.
UROV
| $702K | ﹤0.01% |
+43,551
| New | +$540K |
|
2258
Ranpak Holdings
PACK
$473M
| $701K | ﹤0.01% |
52,162
+41,412
| +385% | +$456K |
|
2259
PUT
UnitedHealth
UNH
$370B
| $701K | ﹤0.01% |
2,000
-7,000
| -78% | -$2.35M |
|
2260
BWX Technologies
BWXT
$15.6B
| $699K | ﹤0.01% |
+11,589
| New | +$668K |
|
2261
HCI Group
HCI
$2.41B
| $699K | ﹤0.01% |
13,358
-5,261
| -28% | -$266K |
|
2262
Employers Holdings
EIG
$889M
| $698K | ﹤0.01% |
21,692
-37,370
| -63% | -$1.21M |
|
2263
Travelzoo
TZOO
$75.4M
| $698K | ﹤0.01% |
73,899
+59,831
| +425% | +$514K |
|
2264
PUT
Arista Networks
ANET
$238B
| $697K | ﹤0.01% |
38,400
-25,600
| -40% | -$406K |
|
2265
CALL
Exelon
EXC
$47B
| $697K | ﹤0.01% |
23,133
-22,712
| -50% | -$670K |
|
2266
CALL
EQT Corp
EQT
$32.3B
| $695K | ﹤0.01% |
+54,700
| New | +$788K |
|
2267
iShares MSCI Brazil ETF
EWZ
$8.95B
| $694K | ﹤0.01% |
18,727
-634,773
| -97% | -$20.5M |
|
2268
Noodles & Co
NDLS
$107M
| $694K | ﹤0.01% |
10,984
+2,107
| +24% | +$130K |
|
2269
Rocky Brands
RCKY
$369M
| $694K | ﹤0.01% |
24,709
+9,733
| +65% | +$277K |
|
2270
PUT
Synaptics
SYNA
$4.15B
| $694K | ﹤0.01% |
7,200
+4,200
| +140% | +$342K |
|
2271
Vertex
VERX
$1.94B
| $694K | ﹤0.01% |
19,917
-50,599
| -72% | -$1.38M |
|
2272
Protara Therapeutics
TARA
$232M
| $692K | ﹤0.01% |
28,599
+18,480
| +183% | +$398K |
|
2273
PUT
Apollo Global Management
APO
$73.4B
| $691K | ﹤0.01% |
14,100
+6,400
| +83% | +$286K |
|
2274
PUT
IMAX
IMAX
$2.66B
| $687K | ﹤0.01% |
+38,100
| New | +$525K |
|
2275
ZTO Express
ZTO
$17.9B
| $687K | ﹤0.01% |
23,547
-58,539
| -71% | -$1.72M |
|
Similar funds
VAM
Two Sigma Investments's Q4 2020 Portfolio in Review
As of Q4 2020, Two Sigma Investments held 3,971 positions worth $34.9B, up 24% from $28.2B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
Two Sigma Investments deployed $1.95B of net new capital in Q4 2020, opening 955 new positions and adding to 1,167 existing holdings. Its largest new stake was Boston Scientific: 6,312,819 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Chevron, an estimated $206M trimmed.
- Two Sigma Investments's largest Q4 2020 buy was Boston Scientific: 6,312,819 shares worth $227M.
- Two Sigma Investments added most to NVIDIA in Q4 2020, an estimated $257M increase.
- Two Sigma Investments's biggest Q4 2020 reduction was Chevron, cutting an estimated $206M.
- Two Sigma Investments fully exited Pfizer in Q4 2020, selling an estimated $252M.
- Two Sigma Investments's ten largest holdings make up 7.4% of its $34.9B portfolio in Q4 2020.
- Two Sigma Investments opened 955 new positions and closed 694 in Q4 2020.
- Two Sigma Investments's portfolio value rose 24% quarter-over-quarter to $34.9B.
Based on Two Sigma Investments's 13F filing for Q4 2020, filed 16 Feb 2021.